If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
22.00    0.40 (1.85%)
Bid:
22.10
Ask:
22.20
Spread: 0.10 (0.452%)
Market Cap: £409.44m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

Maturity date extension: High Yield & Retail Notes

15 Oct 2020 09:19

RNS Number : 1892C
EnQuest PLC
15 October 2020
 

ENQUEST PLC

15 October 2020

 

Automatic extension of maturity date of EnQuest's High Yield Notes and Retail Notes

EnQuest PLC ("EnQuest") today confirms the automatic extension of the maturity date of its 7.00 per cent. Extendable PIK Toggle Notes originally due 2022 (the "Retail Notes") and the anticipated automatic extension of the maturity date of its 7.00 per cent. PIK Toggle Senior Notes originally due 2022 (the "High Yield Notes").

 

Under the existing terms of the Retail Notes, the maturity date is automatically extended to 15 October 2023 (from 15 April 2022) if EnQuest's senior credit facility is not repaid or refinanced in full by 15 October 2020. Similarly, under the existing terms of the High Yield Notes, the maturity date is automatically extended to 15 October 2023 (from 15 April 2022) if the senior credit facility is not repaid or refinanced by 30 October 2020.

 

As previously announced, EnQuest reduced its senior credit facility by $325 million during the financial year ended 31 December 2019 and made a further accelerated voluntary repayment of $35 million in January 2020; no senior credit facility amortisations are due in 2020. At the end of September, the Group's outstanding senior credit facility remained at $425.0 million, excluding payment in kind interest.

 

Further information:

For further information, please visit the Company's Investor Relations website at www.enquest.com/investors or contact:

Investor Relations

EnQuest PLC

Fifth Floor, Cunard House

15 Regent Street

London SW1Y 4LR

United Kingdom

 

Tel: +44 (0)20 7925 4900

DISCLAIMER - INTENDED ADDRESSEES

This announcement is a communication to the market. Nothing in this announcement constitutes an offer of securities for sale in the United States or any other jurisdiction. This announcement does not constitute a prospectus or a prospectus equivalent document.

This announcement has been delivered to you on the basis that you are a person into whose possession this announcement may be lawfully delivered in accordance with the laws of the jurisdiction in which you are located and you may not, nor are you authorised to, deliver this announcement to any other person. The distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities laws of any such jurisdiction.

Your right to access this service is conditional upon complying with the above requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVAWRRBURARA
Date   Source Headline
21st Nov 20197:00 amRNSOperations update
28th Oct 201910:33 amRNSDirector/PDMR Shareholding
21st Oct 201910:11 amRNSDirector/PDMR Shareholding
18th Oct 201910:25 amRNSTotal Voting Rights
11th Oct 201912:13 pmRNSDirector/PDMR Shareholding
9th Oct 20194:27 pmRNSDirector/PDMR Shareholding
2nd Oct 20191:08 pmRNSDirector/PDMR Shareholding
17th Sep 201911:25 amRNSHolding(s) in Company
16th Sep 201911:13 amRNSDirector/PDMR Shareholding
9th Sep 201911:44 amRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSChairman Succession
5th Sep 20197:00 amRNSResults for the six months ended 30 June 2019
2nd Sep 201912:04 pmRNSHolding(s) in Company
28th Aug 20193:22 pmRNSTotal Voting Rights
29th Jul 20199:27 amRNSTotal Voting Rights
17th Jul 201911:30 amRNSDirector/PDMR Shareholding
12th Jul 20193:00 pmRNSDirector/PDMR Shareholding
9th Jul 20199:15 amRNSDirector/PDMR Shareholding
1st Jul 20192:48 pmRNSDirector/PDMR Shareholding
27th Jun 20192:24 pmRNSReport on Payments to Govts
26th Jun 201911:54 amRNSTotal Voting Rights
25th Jun 20193:46 pmRNSDirector/PDMR Shareholding
18th Jun 201911:30 amRNSDirector/PDMR Shareholding
10th Jun 20192:33 pmRNSDirector/PDMR Shareholding
5th Jun 20194:12 pmRNSDirector/PDMR Shareholding
3rd Jun 201912:08 pmRNSDirector/PDMR Shareholding
30th May 20198:30 amRNSBlock Listing Application
28th May 20194:28 pmRNSDirector/PDMR Shareholding
23rd May 20194:54 pmRNSAGM Statement
23rd May 20197:00 amRNSOperations Update
20th May 20193:10 pmRNSDirector/PDMR Shareholding
13th May 20194:15 pmRNSDirector/PDMR Shareholding
8th May 201912:50 pmRNSDirector/PDMR Shareholding
26th Apr 20194:34 pmRNSDirector/PDMR Shareholding
17th Apr 20194:00 pmRNSNotice of AGM and Report & Accounts
8th Apr 201910:20 amRNSDirector/PDMR Shareholding
1st Apr 201911:36 amRNSDirector/PDMR Shareholding
27th Mar 20192:35 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSFinal Results
15th Mar 20197:00 amRNSBoard Appointment
12th Mar 20197:11 amRNSKraken 2P Reserves
5th Feb 20197:00 amRNSOperations update
30th Jan 20193:22 pmRNSBoard Committee Membership
28th Jan 201911:31 amRNSChange of Directors' Details
23rd Jan 201910:08 amRNSHolding(s) in Company
18th Jan 20194:09 pmRNSDirector/PDMR Shareholding
17th Dec 201812:22 pmRNSChange of Director's Details
5th Dec 20187:00 amRNSOperations update
3rd Dec 20187:00 amRNSCompletion of Magnus Transaction
26th Nov 201811:56 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.